August 2020 - Online meeting
Meeting objectives:
- Landscape of HPV Screening
- Discuss barriers to adoption and implementation of HPV testing
- Review quality, validation and availability of HPV tests
- Provide country examples of successful implementation of HPV testing
- Discuss if we have enough options and supply needed for the global cervical cancer elimination
- Review HPV screening and treatment challenges in different regions
- Review challenges and opportunities to offer a complete system, from screening to treatment, in LMIC
- Discuss the existing networks that support the implementation of cervical cancer screening programs in LMICs.
- Triage: what are the best options.
- Review current available triage, treatment and management algorithms
- Discuss what are the best options for different situations
- Review challenges and future opportunities
- Integration of Vaccination and Screening
- How to organize cervical cancer screening in the era of vaccination (Keynote Lecture)
- Impact of COVID-19 on cervical cancer screening programs
(Pdf)
August 27, 2020
SESSION 1: OPENING AND OBJECTIVES
Alex Vorsters
SESSION 2: THE LANDSCAPE OF HPV SCREENING; WHERE DO WE STAND TODAY?
Chairs: Pierre Van Damme & Sharon Hanley
- (Pdf, 905 kB)
Nathalie Broutet
- Quality Review, Validation and Availability of HPV tests
-
Mario Poljak
- Validation of HPV tests usable for cervical cancer screening
Marc Arbyn
- (Pdf, 767 kB)
Anne - Laure Page
- (Pdf, 1.391 kB)
Kate Cuschieri
- ​Questions and Discussions
SESSION 3: HPV SCREENING AND TREATMENT; OPPORTUNITIES AND CHALLENGES IN DIFFERENT REGIONS.
Chairs: Murat Gultekin & Kate Cuschieri
- (Pdf, 1.457 kB)
Michael Chung
- . (Pdf, 2.576 kB)
Mario Poljak
- (Pdf, 2.470 kB)
Svetlana Rogovskaya & N.Chernova
- Implementation of organized HPV-based screening programs; Strategies, Challenges and Successes.
(Netherlands) - (Pdf, 893 kB)
(Turkey) - (Pdf, 2.415 kB)
- Implementation of regional HPV-based screening; Challenges and way forward to national implementation
- (Pdf, 807 kB)
Francesca Carozzi (Italy)
- Road map to implementation of HPV-based screening; Halted implementation, Challenges and way forward.
Mark Van der Bulcke (Belgium)
- Questions and Discussions
PANEL DISCUSSION - SHIFT FROM CYTOLOGY TO HPV TESTING; SOLUTIONS AND OPPORTUNITIES
Chairs: Eduardo Franco & Marc Arbyn
- Shift from Cytology to HPV Testing; Solutions and Opportunities
Panel Discussion
​SESSION 2 CONTINUED: THE LANDSCAPE OF HPV SCREENING; WHERE DO WE STAND TODAY?
Chairs: Anna Giuliano & Susanne Krüger Kjaer
- (Pdf, 1.620 kB)
Jesper Bonde
- (Pdf, 275 kB)
Talia Malagon
- Questions and Discussion
DISCUSSION SESSION
Chairs: Jesper Bonde & Alex Vorsters
- The topics discussed were based on participants’ suggestions via poll
Elimination of HPV; does elimination targets lead to potential shortage of assays?/ Barriers and opportunities in Implementing cervical cancer screening and treatment
August 28, 2020
SESSION 4: TRIAGE; CURRENTLY AVAILABLE OPTIONS, FUTURE OPPORTUNITIES AND CHALLENGES
Chairs: Suzanne Garland & Margaret Stanley
- (Pdf, 2.271 kB)
Silvia de Sanjose
Maribel Almonte
- (Pdf, 2.546 kB)
Lynette Denny
- Questions and Discussions
SESSION 5: EXISTING NETWORKS SUPPORTING IMPLEMENTATION OF CERVICAL CANCER PRECENTION AND CONTROL IN LOW RESOURCE SETTINGS.
Chairs: Silvia de Sanjose & Mira kojouharova
- Existing networks: Findings, Current Perspectives and Way forward
- (Pdf, 1.403 kB)
Somesh Kumar – JHPIEGO
- (Pdf, 2.257 kB)
Kerry Thomson – PATH
- Questions and Discussions
SESSION 6: SCREENING IN THE ERA OF VACCINATION
Chairs: Francesca Carozzi & Nubia Muñoz
- (Keynote lecture) (Pdf, 780 kB)
Eduardo Franco
- Questions and Discussions
SESSION 7: HPV PREVENTION AND CONTROL PROGRAMS IN PANDEMIC SITUATION
Chairs: Mario Poljak & Nathalie Broutet
- (Pdf, 503 kB)
Inge de Kok
- ‸¾¾±²õ³¦³Ü²õ²õ¾±´Ç²Ô
​SESSION 8: CONCLUSION
- and concluding remarks
Marc Baay & Alex Vorsters